Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition • 09-14 May 2026
|
668-02-001.
1H-MRS brain metabolites as biomarkers of high-altitude hypobaric hypoxia following mild traumatic brain injury in mice
Impact: High-altitude hypoxia alters brain metabolism and may reduce brain resilience to mild TBI. MRS reveals neurochemical markers of hypobaric hypoxia indicating neurophysiological
alterations with implications for
military and civilian populations operating in sustained high altitude
environments and space travel.
|
||
|
668-02-002.
Brain GABA and glutathione in people living with HIV
Impact: Brain GABA and GSH are essential for brain development and defense against harmful elements. This study found that HIV presence affects MRS-measured GABA, while smoking and normal aging influence GSH.
|
||
|
668-02-003.
Impaired Neurometabolism in Severe Amyotrophic Lateral Sclerosis Condition: A 1H-[13C]-NMR Analysis in SOD1G93A Mice
Impact: The neurometabolic activity provides an accurate
measure of the degree of motor impairment in ALS conditions.
|
||
|
668-02-004.
Retrospective frequency and phase correction improves SNR and quantification for human brain 31P MRS at 7T
Impact:
Corrections for the gradient heating or subject motion-induced frequency/phase offsets were shown to improve spectral SNR and metabolite quantification for human brain phosphorus MR spectroscopy. Integration of the correction to the data processing may help more accurately characterize bioenergetic abnormalities. |
||
|
668-02-005.
An Automated Reference Based Method for Frequency, Phase, and Baseline Alignment in Quantitative Exchanged Label Turnover MRS
Impact: This
automated baseline-referenced alignment enables accurate correction of spectral
drift across separate MRS scans, improving metabolic analysis in QELT-MRS. It
facilitates reliable detection of labeling-induced changes, supporting robust
metabolic imaging in research and potential clinical translation.
|
||
|
668-02-006.
Evaluating metabolites in metastatic ovarian tumors with and without cytotoxic treatment using 3T MR spectroscopy
Impact: This study demonstrates that ¹H-MRS can identify metabolic changes associated with chemotherapy response in ovarian cancer, highlighting its potential as a noninvasive imaging biomarker for early treatment monitoring and improved assessment of therapeutic efficacy in gynecologic oncology.
|
||
|
668-02-007.
Constraining water dMRI microstructure models with dMRS-derived soma radii
Impact: In this work, soma radii derived from metabolite dMRS, were used to inform water dMRI models (SANDI, SANDIX), improving the robustness of parameter maps. While further work is needed, this marks a promising step toward combining dMRS and dMRI.
|
||
|
668-02-008.
Capturing hippocampal inflammation using diffusion-weighted MR spectroscopy (dw-MRS) and multi-compartment diffusion metrics
Impact: Glial
cells constitute approximately half of brain tissue
but their contributions to multi-compartment diffusion metrics are often
overlooked. Here, we use diffusion-weighted MRS to extract glial-specific
metrics and explore their relationship with multi-compartment diffusion metrics
in the hippocampus.
|
||
|
668-02-009.
31P magnetic Resonance Spectroscopy of the thigh muscles in sarcopenia
Impact: 31P-MRS enables noninvasive, quantitative evaluation of skeletal muscle metabolism. Metabolic markers such as the PCr/Pi ratio may serve as objective indicators of early sarcopenia, complementing conventional structural assessments and facilitating earlier diagnosis and intervention.
|
||
|
668-02-010.
Mapping of GABA and Glutamate in Tuberous Sclerosis Complex Using Edited-MRSI at 3T
Impact: Voxel-wise GABA-edited MRSI showed elevated GABA+ and Glx across tissue types in TSC, suggesting disrupted inhibitory-excitatory balance. These findings highlight potential of GABA-edited MRSI for understanding neurochemical mechanisms in TSC.
|
||
|
668-02-011.
Metabolic Alteration in the Midbrain-Striatal Circuit in Parkinson's Disease: A MEGA-PRESS-based MRS Study
Impact: Identifying PD’s region-specific
metabolic network dysregulation and neurochemical changes provides new
quantitative evidence for understanding its pathology and guides targeted
neurochemical system intervention.
|
||
|
668-02-012.
Sleep-related changes in 1H MRS-visible macromolecules
Impact: Noninvasive methods for evaluating brain clearance are of increasing
interest, given the importance of clearance processes for brain health. Macromolecular
signals from MRS may represent a promising noninvasive marker for brain
clearance, complementary to neurofluid transport markers from MRI.
|
||
|
668-02-013.
Assessment of diurnal metabolism in lumbar paraspinal muscles in vivo using 31P-MRS at 3T
Impact: This study provided
a reference for exploring the application of ³¹P-MRS in systemic muscle
metabolism and pathological changes in clinical practice.
|
||
|
668-02-014.
Regional Alterations in Brain Energy and Membrane Phospholipid Metabolism in Smokers: A 31P Chemical Shift Imaging Study
Impact: This study reveals region-specific metabolic disturbances in the smoking brain, highlighting altered energy balance and membrane metabolism underlying cognitive and neurologic effects. The frontal lobe demonstrates pronounced alterations, offering insights into neurobiologic mechanisms of smoking-related cognitive and neurologic risks.
|
||
|
668-02-015.
Revisiting an Aspect of GBCA Stability in the Context of Copper Metabolism Disorders through Relaxometry Insights
Impact: Presence
of Cu²⁺ significantly increases the release of Gd3+ from GBCAs in
the presence of glycosaminoglycans. This may increase the risk of gadolinium deposits
in cases of copper-metabolism disorders, and this link should be further
investigated in future research.
|
© 2026 International Society for Magnetic Resonance in Medicine